Epidermal growth factor receptor levels increase but epidermal growth factor receptor ligand levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence
| Autor: | Mels Sluyser, Clemens B. M. Kienhuis, C.C.J. De Goeij, P. G. Koenders, Theo J. Benraad |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Male
Cancer Research medicine.medical_specialty Neoplasms Hormone-Dependent medicine.medical_treatment Mammary gland Estrogen receptor Biology Ligands Mice Cytosol Epidermal growth factor Internal medicine Progesterone receptor medicine Animals Epidermal growth factor receptor Receptor Mammary tumor Mammary Neoplasms Experimental ErbB Receptors Steroid hormone Disease Models Animal medicine.anatomical_structure Endocrinology Oncology Receptors Estrogen biology.protein Female Receptors Progesterone |
| Zdroj: | Breast cancer research and treatment. 26(3) |
| ISSN: | 0167-6806 |
| Popis: | Twenty-six serially transplanted Grunder (GR) strain mouse mammary tumors were analyzed for epidermal growth factor receptor (EGFR) and EGFR-ligand levels, in addition to steroid hormone receptors (estrogen receptor, ER, progesterone receptor, PgR). In concordance with earlier studies, hormone dependent (HD) and hormone responsive (HR) tumors were found to be positive for both ER and PgR, whereas hormone independent (HI) tumors contained only 30% of the ER concentration that was found in the HD tumors. PgR was undetectable in HI tumors. HI tumors contained 2.5 to 3-fold higher EGFR levels than HD/HR tumors, an observation which shows remarkable concordance with studies on EGFR in human breast cancer. On the other hand, the level of EGFR-ligand(s) was positively associated with ER levels and was three-fold higher in HD/HR tumors than in HI tumors. The low EGFR in HD/HR tumors relative to HI tumors may be the result of downregulation by EGFR ligands produced under ER control. During progression to hormone independence this downregulation of EGFR is then abolished in absence of ER. The increase in EGFR may therefore be a secondary effect rather than a key event in the progression to hormone independence in this mouse mammary tumor model. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink